Pierre Legault's Net Worth

$12.8 Million

Estimate Recalculated Apr 22, 2024 03:06PM EST

Who is Pierre Legault?

Pierre Legault has an estimated net worth of $12.8 Million. This is based on reported shares across multiple companies, which include BICYCLE THERAPEUTICS plc, Syndax Pharmaceuticals Inc, RITE AID CORP, ARMO BioSciences, Inc., Urovant Sciences Ltd., Alliqua BioMedical, Inc., Cyclacel Pharmaceuticals, Inc., NPS PHARMACEUTICALS INC, Forest Laboratories, LLC, Regado Biosciences Inc, NephroGenex, Inc., and OSI PHARMACEUTICALS INC.

SEC CIK

Pierre Legault's CIK is 0001391045

Past Insider Trading and Trends

2021 was Pierre Legault's most active year for acquiring shares with 12 total transactions. Pierre Legault's most active month to acquire stocks was the month of December. 2021 was Pierre Legault's most active year for disposing of shares, totalling 28 transactions. Pierre Legault's most active month to dispose stocks was the month of February. 2009 saw Pierre Legault paying a total of $4,971,250.00 for 181,500 shares, this is the most they've acquired in one year. In 2010 Pierre Legault cashed out on 181,500 shares for a total of $10,397,885.56, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BICYCLE THERAPEUTICS plc (BCYC) Snapshot price: $17.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+55.81%
12K
—
—
33.5K
Jan 2
Form 4
+115.00%
11.5K
—
—
21.5K
Jan 3
Form 4
∞
10K
—
—
10K
Jan 3
Form 4
—
0
$33.08
-$7,384,203.42
0
Scheduled
Dec 20 - Dec 22
Form 4
—
0
$20.23
-$570,503.55
0
Scheduled
Apr 8
Form 4
—
0
$19.95
-$3,602.88
0
Scheduled
Apr 5
Form 4
—
0
$19.39
-$212,200.00
0
Scheduled
Mar 31
Form 4
—
0
$18.93
-$156,847.60
0
Mar 17
Form 4
—
0
$18.93
-$44,630.24
0
Mar 12
Form 4
—
0
—
—
0
Jan 4
Form 4/A
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
May 28
Form 3
—
0
—
—
0
No matching records found

Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+35.42%
17K
—
—
65K
Feb 7
Form 4
+50.00%
16K
—
—
48K
Feb 2
Form 4
—
0
$18.95
-$615,801.60
32K
Scheduled
Jan 12 - Jan 13
Form 4
—
0
$16.12
-$331,061.60
32K
Scheduled
Aug 5
Form 4
+100.00%
16K
—
—
32K
Feb 2
Form 4
—
0
$14.54
-$617,736.40
16K
Scheduled
Dec 20 - Dec 22
Form 4
∞
16K
—
—
16K
Feb 3
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Jan 4
Form 3
—
0
—
—
0
No matching records found

RITE AID CORP (RADCQ) Snapshot price: $0.13

Senior Executive VP

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.50%
-3.13K
$1.35
-$4,232.25
206.5K
Jun 26
Form 4
+91.21%
100K
—
—
209.64K
Jun 24
Form 4
-10.98%
-13.53K
$2.22
-$30,029.94
109.64K
Jun 7
Form 4
+23.17%
23.17K
—
—
123.17K
Jun 26
Form 4
∞
100K
—
—
100K
Jun 7
Form 3
—
0
—
—
0
No matching records found

ARMO BioSciences, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Mar 26
Form 3
—
0
—
—
0
No matching records found

Urovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-21.48K
—
—
0
Mar 29
Form 4
+72.12%
9K
—
—
21.48K
Jul 21
Form 4
∞
12.48K
—
—
12.48K
Jan 10
Form 4
—
0
—
—
0
Jul 9
Form 4
—
0
—
—
0
Nov 21
Form 3
—
0
—
—
0
No matching records found